A proprietary transdermal delivery system utilizing sufentanil, a potent opioid, for the treatment of chronic pain.
View complete product pipeline
May 10, 2013DURECT Announces Update on Remoxy®
May 02, 2013DURECT Corporation Announces First Quarter 2013 Financial Results and Update of Programs
April 16, 2013DURECT Announces Submission of New Drug Application for POSIDUR™ (SABER®-Bupivacaine)
February 28, 2013DURECT Corporation Announces Fourth Quarter 2012 Financial Results and Update of Programs